Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

November 7, 2023 Total investment from the Bill & Melinda Gates Foundation reaches USD 60 million, accelerating expansion of new AI-guided ultrasound capabilities on Philips Lumify Handheld Ultrasound Innovation helps address worldwide shortage of healthcare workers by putting diagnostic tool previously reserved for expert technicians in the hands of midwives Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received a second round of funding from the Bill & Melinda Gates Foundation to accelerate global adoption of AI algorithms on Philips Lumify Handheld Ultrasound. By using AI to simplify key measurements to identify abnormalities during pregnancy, training time to use the ultrasound system can be reduced from weeks to just hours, hugely expanding the pool of frontline health workers who can learn to use the technology and integrate it into routine care.

Philips program developing AI-powered ultrasound to expand access to maternal health receives major funding boost

BILLERICA, Mass.--(BUSINESS WIRE)--E Ink (8069.TWO), the originator, pioneer, and global commercial leader in ePaper technology, announced today that their customer, PPDS, announced the latest evolution of its multi-award-winning ePaper signage range, with the launch of the new 32-inch (16:9) Philips Tableaux 5150I Series using E Ink Spectra 6. E Ink launched Spectra 6 in April 2023 at Touch Taiwan, showcasing a level of color saturation and vividness not previously seen in a reflective display.

E Ink's Customer PPDS Launches First 32-inch Philips Tableaux ePaper Display Using E Ink Spectra™ 6

November 2, 2023 Amsterdam, the Netherlands and Farnborough, UK – Royal Philips  (NYSE: PHG, AEX: PHIA), a global leader in health technology and County Durham and Darlington NHS Foundation Trust (CDDFT), one of the largest integrated care providers in England, today announced the results of a comprehensive 360 sustainability analysis. The program identified key opportunities to reduce the carbon footprint and waste material within the intensive care unit (ICU) at Darlington Memorial Hospital.

Philips and County Durham and Darlington NHS Foundation Trust collaborate on a sustainability blueprint to reduce carbon emissions and waste

November 1, 2023 Reaching 15 million people in the region in 2022 alone [1], the foundation sets out plans to ramp up collaboration with social entrepreneurs Amsterdam, the Netherlands and Nairobi, Kenya – Philips Foundation, with its mission to provide access to quality healthcare for 100 million people a year by 2030, reports today on the significant progress made in improving access to maternal healthcare in Sub-Saharan Africa. Over five years across five distinct projects, Philips Foundation has made substantial progress through unique collaborations , improving access to maternal care for 15 million people in 2022 alone [1].

Philips Foundation marks five years of improving access to maternal care in Sub-Saharan Africa and sets out future plans

October 26, 2023 Safety of Philips' iFR in the guidance of percutaneous coronary intervention (PCI) for heart disease demonstrated in late-breaking science at TCT 2023 highlighting patient-level outcomes analysis of 42,000 patients from the National Swedeheart Quality Registry Previous data demonstrate that iFR delivers consistent patient outcomes, reduces discomfort and offers a more cost-effective and faster diagnostic solution [1,2] compared to FFR Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the latest results demonstrating the safety of Philips instant wave-free ratio (iFR) in the guidance of PCI. Philips is committed to clinically validating its innovations in cardiac and cardiovascular care.

iFR and FFR are equally safe to diagnose and treat heart disease according to largest-ever analysis of new real-world, long-term data

Philips' (PHG) third-quarter results benefit from strong momentum across the Diagnosis & Treatment, Connected Care and Personal Health businesses.

Philips (PHG) Q3 Earnings Beat Estimates, Revenues Rise Y/Y

Koninklijke Philips N.V (NYSE:PHG ) Q3 2023 Earnings Call Transcript October 23, 2023 4:00 AM ET Company Participants Leandro Mazzoni - Head of IR Roy Jakobs - CEO Abhijit Bhattacharya - CFO Conference Call Participants Hassan Al-Wakeel - Barclays David Adlington - JPMorgan Richard Felton - Goldman Sachs Lisa Clive - Alliance Bernstein Robert Davies - Morgan Stanley Veronika Dubajova - Citi Hugo Solvet - BNP Paribas Graham Doyle - UBS Sezgi Bice Ozener - HSBC Falko Friedrichs - Deutsche Bank Operator Welcome to the Royal Philips Third Quarter 2023 Results Conference Call on Monday, October 23, 2023. During the call, hosted by Mr.

Koninklijke Philips N.V (PHG) Q3 2023 Earnings Call Transcript

American depositary receipts (ADRs) of Philips (PHG) advanced as the health technology firm posted better-than-expected results and raised its outlook on improved operational performance.

Philips' Profit Rises After Simplifying Operations and Shoring Up Its Supply Chains

Dutch medical device maker Philips raised its 2023 earnings outlook on Monday after posting stronger third quarter sales and profits despite a recent setback for its sleep machines in the United States.

Philips raises outlook despite sleep machine saga

Dutch health technology company Philips on Monday raised its full-year outlook as it beat analyst expectations with a more than doubling of third-quarter core profit to 457 million euros ($483.3 million).

Dutch health tech company Philips raises outlook as Q3 profit jumps

October 23, 2023 Third-quarter highlights Group sales increased 11% on a comparable basis to EUR 4.5 billion Income from operations at EUR 224 million, compared to a loss of EUR 1,529 million in Q3 2022 Adjusted EBITA increased to EUR 457 million, or 10.2% of sales, compared to EUR 209 million, or 4.8% of sales, in Q3 2022 Comparable order intake was -9% compared to Q3 2022; order book remains strong Operating cash flow improved to EUR 489 million, compared to an outflow of EUR 180 million in Q3 2022 Restructuring and productivity plans on track with total savings of EUR 258 million in the quarter Outlook for full-year 2023 raised to 6-7% comparable sales growth and an Adjusted EBITA margin of 10-11% Roy Jakobs, CEO of Royal Philips: “Our improved operational performance was driven by our focus on execution to enhance patient safety and quality, strengthen our supply chain reliability and establish a simplified operating model. The order book remains strong, and we are taking the necessary actions to improve order intake by shortening lead times from order to delivery and building on the positive impact we are making with our innovations, for example in predictive data analytics and artificial intelligence across our portfolio, to help improve the quality and efficiency of care delivery.

Philips delivers strong sales growth, profitability and cash flow; raises full-year outlook

Koninklijke Philips' (PHG) third-quarter results are likely to reflect strength in the Diagnosis & Treatment and Connected Care segments amid macroeconomic challenges.

What's in the Cards for Koninklijke Philips' (PHG) Q3 Earnings?

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that once again, the company earned a spot on Forbes' 2023 “World's Best Employers” list. Philips has appeared within the top 100 for the past four years, and holds this position among the 700 organizations around the globe that were included in the 2023 list. Philips' ranking identifies the company as the best employer in the world in the Health Care Equipment & Se.

Philips ranks #1 in ‘Health Care Equipment & Services' sector on Forbes' 2023 ‘World's Best Employers' List

October 19, 2023 Sustainability roadmap addresses opportunities to reduce carbon emissions in patient throughput, technology use, and use of consumables Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the completion of a comprehensive hospital-wide analysis of Tampere Heart Hospital – Tampere University Hospital's (Finland) environmental sustainability, including a deep assessment of the interventional cardiology space and evaluation of its carbon footprint. The results of the analysis have been translated into a joint action plan that will help Heart Hospital accelerate its decarbonization efforts in line with Finland's world-leading commitment to reach net zero emissions by 2035.

Philips supports Tampere Heart Hospital in Finland to decarbonize its clinical operations

Philips (PHG) launches Visual Patient Avatar to help anesthesiologists with situational awareness in operating rooms, boosting their clinical confidence.

Philips (PHG) Aids Clinicians With New Monitoring Solution

October 13, 2023 Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Visual Patient Avatar , a revolutionary new monitoring solution that translates critical, yet complex patient data into a straightforward visual design as an easy-to-understand avatar display.   In today's operating rooms (ORs), time constraints and information overload contribute to poor situational awareness, which is responsible for 81.5% of anesthesia-related errors [1].

Philips Visual Patient Avatar pioneers at-a-glance patient data for faster, better decision-making in the operating room

Exor recently entered Philips with a 15% equity stake (and optionality to arrive at 20%). PHG agrees to conduct additional testing and notes ongoing communication and cooperation with the FDA. Here at the Lab, we estimate at least €3 billion in damage. The controversy surrounding the recall of Philips' defective devices continues to impact the stock price (and reputation).

Koninklijke Philips: Hold For Now

October 10, 2023 Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge Philips' leadership in the rapid end-to-end treatment of stroke helping to improve patient outcomes and increase the efficiency of treatment Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the World Stroke Organization (WSO) , the world's only global non-governmental organization focused on stroke, today announced the signing of a two-year partnership aimed at improving access to high-quality stroke care. Building on their shared commitment to delivering improvements in stroke prevention, treatment, rehabilitation and support, Philips and WSO will leverage their respective strengths to elevate the public understanding of stroke as a global health issue, starting with joint initiatives on World Stroke Day 2023 (October 29) to build greater public awareness, which is fundamental to improving stroke patient outcomes.

Philips and World Stroke Organization partner to improve access to high-quality stroke care

October 10, 2023 Interoperability of Philips Capsule Medical Device Information Platform (MDIP) with Philips Patient Information Center iX (PIC iX) includes streaming, vendor-neutral data to support care delivery and collaboration Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the interoperability of Philips Capsule Medical Device Information Platform (MDIP) with Philips Patient Information Center iX (PIC iX), providing hospitals with a first-of-its-kind, comprehensive patient overview. As a world leader monitoring more than 600 million patients each year worldwide, Philips is creating an open patient monitoring ecosystem to bring together disparate medical devices and systems on a single interface.

Philips announces new interoperability capabilities that offer a comprehensive view of patient health for improved monitoring and care coordination

American depositary receipts (ADRs) of Koninklijke Philips (PHG) sank in early trading on Friday as the Food and Drug Administration (FDA) ruled the Netherlands-based health tech firm's handling of a recall of sleep apnea devices was not sufficient.

Philips ADRs Slide as FDA Says It's Unsatisfied With Sleep Apnea Machine Recall

Philips said it would do the additional testing the FDA is requiring. The company recently settled some claims regarding the recalled products but faces other legal challenges.

Why Shares of Koninklijke Philips Are Falling on Friday

The shares of Koninklijke Philips NV (NYSE:PHG) are plummeting in premarket trading this morning, as the Dutch healthcare tech company comes under fire from the U.S. Food and Drug Administration (FDA).

Philips Stock Sinks Amid FDA Accusations

Shares of Dutch health tech company Philips fell on Friday after the U.S. drug regulator deemed its handling of a major product recall inadequate.

Philips shares fall 8% after U.S. drug regulator deals fresh blow to sleep device recall

The U.S. Food and Drug Administration (FDA) remains unsatisfied with the status of a product recall by healthcare technology company Philips , the regulator said in an update.

FDA says it is not satisfied with Philips breathing device recall

Abbott Labs

Smith & Nephew

Here we pick three stocks, Abbott Laboratories (ABT), Koninklijke Philips (PHG) and Smith & Nephew SNATS (SNN) from the Medical - Products industry, with a solid five-year dividend growth history.

News for Royal Philips Stock (PHG)